State NJ
Clinical Trials in New Jersey
New Jersey is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in New Jersey and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in New Jersey
Frequently Asked Questions — Clinical Trials in New Jersey
How many clinical trials are currently recruiting in New Jersey?
ClinicalMetric currently tracks 237 actively recruiting clinical trials with at least one location in New Jersey. The total number of registered studies—including active but not currently enrolling trials—is 237. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in New Jersey?
New Jersey hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Multiple Myeloma, Pancreatic Ductal Adenocarcinoma, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout New Jersey serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in New Jersey?
To join a clinical trial in New Jersey, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in New Jersey maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in New Jersey
NCT06725511 N/A
Recruiting
Wellness Program Outreach and Effectiveness
Condition
Metabolic Syndrome
Enrollment
2,000 pts
Location
United States
Sponsor
Massachusetts Institute of Tec
NCT04998552 N/A
Recruiting
Safety of Cyberknife in Patients With Borderline Resectable or Locally Advanced ...
Condition
Pancreas Adenocarcinoma
Enrollment
10 pts
Location
United States
Sponsor
Capital Health System, Inc
NCT06986083 Phase 3
Recruiting
A Study of Changes to Prostate Procedures
Condition
Prostate Cancer
Enrollment
800 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT06386874 N/A
Recruiting
EMAGINE 2.0 - Electromagnetic Field Ischemic Stroke - Novel Subacute Treatment
Condition
Ischemic Stroke
Enrollment
122 pts
Location
United States
Sponsor
BrainQ Technologies Ltd.
NCT05537610 N/A
Recruiting
Extensions of Resurgence as Choice
Condition
Problem Behavior
Enrollment
30 pts
Location
United States
Sponsor
Rutgers, The State University
NCT05799274 Phase 1
Recruiting
Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer...
Condition
Healthy Volunteers
Enrollment
9 pts
Location
United States
Sponsor
Radiopharm Theranostics, Ltd
NCT06609980 Phase 1
Recruiting
Restoration of Antibiotics Related Infant Microbiota Perturbations by Autologous...
Condition
Antibiotic Treatment
Enrollment
100 pts
Location
United States
Sponsor
Rutgers, The State University
NCT07349810 Phase 4
Recruiting
Post Operative Infusion Pump Pain Study
Condition
Post Operative Pain
Enrollment
80 pts
Location
United States
Sponsor
Rutgers, The State University
NCT04293562 Phase 3
Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilterit...
Condition
Acute Myeloid Leukemia
Enrollment
1,186 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT06841198 N/A
Recruiting
Cardiovascular Function and Response to Stimulation Within the First Year After ...
Condition
Spinal Cord Injuries (SCI)
Enrollment
5 pts
Location
United States
Sponsor
Kessler Foundation
NCT07007312 Phase 3
Recruiting
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With...
Condition
Acute Myeloid Leukemia (AML)
Enrollment
1,300 pts
Location
United States, Czechia, France
Sponsor
Kura Oncology, Inc.
NCT07262619 Phase 1, Phase 2
Recruiting
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inh...
Condition
Advanced Solid Tumors
Enrollment
160 pts
Location
United States, Australia, New Zealand
Sponsor
Eikon Therapeutics
NCT05009992 Phase 2
Recruiting
Combination Therapy for the Treatment of Diffuse Midline Gliomas
Condition
Diffuse Intrinsic Pontine Glioma
Enrollment
360 pts
Location
United States, Australia, Israel
Sponsor
University of California, San
NCT06618287 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Effic...
Condition
Lung Cancer
Enrollment
416 pts
Location
United States, Australia, Canada
Sponsor
Bristol-Myers Squibb
NCT06253871 Phase 1
Recruiting
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Condition
HER2 Mutation-Related Tumors
Enrollment
383 pts
Location
United States, France, Ireland
Sponsor
Iambic Therapeutics, Inc
NCT06237452 Phase 3
Recruiting
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Condition
Clostridium Difficile
Enrollment
852 pts
Location
United States, Australia, Belgium
Sponsor
Vedanta Biosciences, Inc.
NCT06112418 N/A
Recruiting
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Pr...
Condition
Diabetes Mellitus, Type 2
Enrollment
7,500 pts
Location
United States
Sponsor
Cleerly, Inc.
NCT06297590 Phase 1
Recruiting
A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzhe...
Condition
Alzheimer Disease
Enrollment
48 pts
Location
United States, Japan, United Kingdom
Sponsor
Eli Lilly and Company
NCT07174310 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in ...
Condition
Parkinson's Disease
Enrollment
900 pts
Location
United States, Australia, Austria
Sponsor
Hoffmann-La Roche
NCT06825897 N/A
Recruiting
Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With...
Condition
Stroke, Acute
Enrollment
2,039 pts
Location
United States
Sponsor
Santiago Ortega Gutierrez
NCT06297226 Phase 2
Recruiting
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Ther...
Condition
Multiple Myeloma
Enrollment
230 pts
Location
United States, Australia, Canada
Sponsor
Juno Therapeutics, Inc., a Bri
NCT07265674 Phase 3
Recruiting
A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (P...
Condition
Advanced Biliary Tract Cancer
Enrollment
480 pts
Location
United States
Sponsor
J-Pharma Co., Ltd.
NCT05636176 Phase 3
Recruiting
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People...
Condition
Heart Failure
Enrollment
5,600 pts
Location
United States, Argentina, Australia
Sponsor
Novo Nordisk A/S
NCT05382338 Phase 3
Recruiting
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hear...
Condition
Childhood Medulloblastoma
Enrollment
225 pts
Location
United States, Canada
Sponsor
Children's Oncology Group
NCT06703476 Phase 3
Recruiting
A Study of Surgical Techniques During Cystectomy
Condition
Bladder Cancer
Enrollment
530 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
Page 1 of 10 — 237 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology